< Back to latest news & events

Event

IPBC Europe 2021

October 2021

Event date: 4th October 2021

IPBC Europe: Leadership Summit will be held in-person on 4-5 October in Dublin.

The conference is the top European gathering of senior corporate IP professionals. It will be covering the key topics affecting the IP Industry in 2021.

HGF’s Partners Craig Thomson, Dr Chris Benson, European Patent Attorney Sarah McCrann and Patent Attorney Cassandra Smith will be attending the event.

Craig Thomson will also be joining and moderating a panel ‘IP in the boardroom: improving for tomorrow‘ on Monday 4th October:

If IP is the valuable asset so many believe it to be, why do so few C-suite executives engage with it in that way and do the events of the last 18 months offer an opportunity to reframe the narrative at boardroom level? Has the pandemic changed views?

  • Effective internal communication of IP value
  • Managing IP as a value centre, not a cost centre
  • The pandemic’s IP value creation lessons

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

The EPO Board of Appeal’s decision in T 1418/22 gives useful guidance on the inventiveness of polymorph claims in Europe. Starting from a known amorphous form, a specific crystalline form …

Read article

HGF Celebrates Two Nominations at the Women and Diversity in Law Awards

We are proud to share that we have been nominated for two awards at The Women and Diversity in Law Awards which will take place on 18th March at Hilton …

Read article